Total Funding
81
30
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1139319
SenoRx is a medical device company that develops invasive technologies for breast cancer diagnosis and treatment.
Acquired by 
C. R. Bard
About the Company
SenoRx, Inc. was formerly known as BiopSolation Medical, Inc. and changed its name to SenoRx, Inc. in April 1998. The company was incorporated in 1998 and is headquartered in Irvine, California. As of July 6, 2010, SenoRx, Inc. operates as a subsidiary of Bard Peripheral Vascular, Inc.
They develop, manufacture and sell minimally-invasive
medical devices for the diagnosis of breast cancer. Their initial product focus has been biopsy systems and breast tissue markers. They also are developing products for use in the treatment of breast cancer.
